01/09/2026
LiverWELL welcomes a significant step forward for hepatitis B elimination in Australia.
This is the result of years of advocacy from Hepatitis Australia, ASHM and sector partners, and we’re delighted to see this barrier to care removed.
More clinicians being able to prescribe means more people living with hepatitis B can access the care they need.
From today, Australian clinicians no longer need specialist accreditation to prescribe s100 hepatitis B antiviral prescriptions.
This change is a major step towards eliminating hepatitis B as a public health threat in Australia. By increasing the number of clinicians able to prescribe treatment, more people can access the care they need, when they need it.
The reform reflects years of advocacy by ASHM, Hepatitis Australia, and sector partners, and reinforces our commitment to removing barriers to hepatitis B care. We will continue advocating for policies and programs that expand access to testing and treatment, reduce health inequities, and support Australia’s progress towards hepatitis B elimination targets.
For clinicians who are new to prescribing hepatitis B treatment, ASHM offers clinical support and expert guidance to build confidence and capability. For existing prescribers, we will continue to provide the same resources and support.
Read more about what the changes mean on the ASHM website: https://buff.ly/uUTxVmP